Smart Liposomes: How Coatings and Targeting Improve Uptake
A bare liposome can be fragile in the digestive tract. To fix this, formulators coat and modify the surface — with biopolymers like chitosan, sodium alginate, or hyaluronate — so the vesicle can withstand stomach acid, adhere to and cross the intestinal lining, and release its cargo where absorption actually happens. The results in the literature can be dramatic, with several-fold increases in oral bioavailability.
Why the surface matters
The intestinal environment can rupture unprotected liposomes before they deliver anything. Surface engineering controls how long the vesicle survives, how it interacts with the gut wall, and when it releases the nutrient — turning a simple bubble into a targeted delivery system. Particle size and surface charge feed into this too: vesicles are typically 100-200 nm, and a zeta potential (surface charge) helps prevent aggregation and supports stability (PMC9781429, PMC10180326). A coating can raise or reverse that charge, changing how the vesicle sticks to the mucus layer lining the gut. It can also slow the point at which the bilayer begins to release its cargo, so the nutrient is available at the absorptive surface of the small intestine rather than being lost earlier.
Common coatings and what they do
- Chitosan and sodium alginate. Polymer coatings that protect the liposome through the stomach and help it adhere to and cross the intestinal lining; coated systems have reported roughly 4.2-6 fold increases in oral bioavailability (PMC10383520).
- Hyaluronate. Used to augment oral delivery and stability; hyaluronate-based liposomes reported about a 4.38-fold increase versus the free compound (PMC8510464).
- Other biopolymers. Starches, gelatin, proteins, cellulose, pectin, and PEG are all used to tune protection, adhesion, and release behavior (PMC10180326).
How a coating survives the stomach
The trick with an oral liposome is timing: it must hold together through the acidic stomach and open in the intestine, where uptake occurs. Mucoadhesive polymers like chitosan cling to the gut lining, slowing transit so there is more time for absorption, while a coating shields the underlying bilayer from acid and bile. This is why a coated vesicle can outperform a bare one so substantially — the several-fold bioavailability gains reported for alginate/chitosan and hyaluronate systems reflect cargo that would otherwise have been lost before reaching the absorptive surface (PMC10383520, PMC8510464).
Targeting and lymphatic transport
Beyond protection, surface design can steer where cargo goes. Some formulations promote intestinal lymphatic transport — lipids assembled as 2-monoacylglycerol are packaged into chylomicrons that travel via the lymph, partly bypassing liver first-pass metabolism (PMC11164214). Because the lymphatic route handles fat-associated molecules, it is especially relevant for poorly water-soluble actives that would otherwise be heavily metabolized on their first pass through the liver. As a benchmark of how much surface and formulation choices move the needle, a ginsenoside Rg1 liposome reported a relative bioavailability of 122.67% (PMC11076820). Research groups have also studied surface-modified nanocarriers aimed at specific tissues, such as amphiphilic carriers designed to deliver curcumin toward neural targets — work that remains research-stage rather than a consumer claim (PMC6313553).
The takeaway for supplements
Two products can both say liposomal and perform very differently depending on this surface design. It is a major reason absorption results vary between brands, and it is why the coating and targeting choices deserve as much attention as the nutrient inside. When a product describes its coating and particle characteristics, that transparency is itself a useful quality signal. The multi-fold bioavailability figures reported in the research — for example the roughly 4.2-6 fold gains for alginate/chitosan systems (PMC10383520) — come from careful surface engineering, not from the phospholipid alone, so a bare liposome should not be assumed to match them.
Coatings for other delivery routes
Surface design is not only about the gut. On the skin, the outermost layer — the stratum corneum — is a formidable barrier, and liposome lipids can interact with the skin's own lipids to help carry actives; flexible nano-vesicles have been studied to improve the stability and release of compounds like curcumin in topical use (PMC11597254, PMC4379890). Researchers have likewise explored surface-modified carriers aimed at the nervous system, where the blood-brain barrier is highly selective, including amphiphilic nanocarriers for curcumin directed at neural targets and intranasal liposome approaches (PMC6313553, PMC4716722). These remain research-stage explorations rather than consumer claims, but they show how far the same surface-engineering logic can be pushed.
A liposome's shell is where much of the engineering — and the performance difference — actually lives.
Frequently asked questions
What are liposomes coated with?
Common coatings include chitosan, sodium alginate, and hyaluronate, along with starches, gelatin, proteins, cellulose, pectin, and PEG — biopolymers that help the vesicle survive digestion and reach the intestine.
How much can coatings improve absorption?
It depends on the system, but coated liposomes have reported multi-fold gains — roughly 4.2-6 fold for alginate/chitosan systems and about 4.38-fold for hyaluronate-based ones versus the free compound.
Why do some liposomal products absorb better than others?
Surface engineering, particle size, and phospholipid quality differ between products, so performance varies even when both are labeled liposomal.
What is lymphatic transport?
A route that carries certain fat-associated nutrients through the lymph system as chylomicrons, partly bypassing the liver's first-pass metabolism and supporting delivery.
Sources: PMC10383520; PMC8510464; PMC11076820; PMC11164214; PMC9781429; PMC10180326; PMC6313553; PMC11597254; PMC4379890; PMC4716722. Educational content about nutrient delivery; not medical advice.